Expertise
Derisk development and clinical trials early
We are a specialized CRO with advanced, fast, custom Immunological interaction technologies in clinically relevant conditions.
- Immunology
- Immunotherapy
- Clinical trials
CTO
Vixen Bio
Gent, Belgium
At Vixen Bio we derisk development and clinical trials early by fast, custom bio-analytical services in clinically relevant conditions.
As a scientist and entrepreneur, I’ve always been driven by the intersection of innovation and real-world application. My career began with a PhD at KU Leuven, where I focused on developing a novel biosensor platform—an experience that sparked both deep technical expertise and a passion for translating research into impactful solutions.
During my PhD, I co-founded Encert, a small company providing energy certificates, gaining early hands-on experience in business operations and client services. This blend of science and entrepreneurship eventually led to the founding of a spin-off company in 2019, centered on the commercial potential of the biosensor technology developed during my doctoral work.
Currently, I serve as Chief Technology Officer at Vixen Bio, a dynamic service provider specializing in biomolecular interaction analysis. We support therapeutic and diagnostic development through cutting-edge biophysical characterization, enabling faster and more informed decision-making for our partners in biotech and pharma.
With a strong foundation in biosensor R&D, entrepreneurial drive, and leadership in biotech services, I’m passionate about bridging the gap between advanced science and industry needs.
Skills
Interests
Expertise
Derisk development and clinical trials early
We are a specialized CRO with advanced, fast, custom Immunological interaction technologies in clinically relevant conditions.